Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

43.28
Delayed Data
As of Jun 24
 -1.31 / -2.94%
Today’s Change
31.25
Today|||52-Week Range
58.46
-23.49%
Year-to-Date
3 Biotech Stocks to Buy in July
3:22pm / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close44.59
Today’s open42.20
Day’s range41.56 - 44.71
Volume8,931,812
Average volume (3 months)1,160,265
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-85.83%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book8.80

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-11.34-7.35%
ACADACADIA Pharmaceutica...-2.07-6.18%
GRFSGrifols SA-0.58-3.61%
ENDPEndo International P...-0.99-6.25%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs